FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/08/072640 [Registered on: 19/08/2024] Trial Registered Prospectively
Last Modified On: 08/08/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   comparing three different spinal drugs for hernia surgery cases - Drugs Bupivacaine, ropivacaine and Levobupivacaine.  
Scientific Title of Study   Comparison of intrathecal Ropivacaine, Levobupivacaine and Bupivacaine for elective hernioplasty: A prospective randomised controlled trial  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  A. Anusha 
Designation  Assistant professor 
Affiliation  Bhaarath medical college and hospital 
Address  F4, BHEL nagar, Medavakkam, Chennai.

Chennai
TAMIL NADU
600100
India 
Phone  9003517979  
Fax    
Email  anushaambal@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  A. Anusha 
Designation  Assistant professor 
Affiliation  Bhaarath medical college and hospital 
Address  F4, BHEL nagar, Medavakkam, Chennai.


TAMIL NADU
600100
India 
Phone  9003517979  
Fax    
Email  anushaambal@gmail.com  
 
Details of Contact Person
Public Query
 
Name  A. Anusha 
Designation  Assistant professor 
Affiliation  Bhaarath medical college and hospital 
Address  F4, BHEL nagar, Medavakkam, Chennai.


TAMIL NADU
600100
India 
Phone  9003517979  
Fax    
Email  anushaambal@gmail.com  
 
Source of Monetary or Material Support  
Bhaarath medical college and hospital.  
 
Primary Sponsor  
Name  Dr A Anusha 
Address  F4, BHEL nagar, Medavakkam, Chennai. 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr A Anusha  Bhaarath medical college and hospital  173, Agaram main road, Selaiyur, Chennai.
Chennai
TAMIL NADU 
9003517979

anushaambal@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Bhaarath Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical, (2) ICD-10 Condition: K409||Unilateral inguinal hernia, without obstruction or gangrene,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  spinal anesthesia   intervention in spinal anesthesia is tried and data compared with 3 different hyperbaric drugs for their onset, duration and maximum level. 
Comparator Agent  spinal anesthesia  spinal anesthesia with 0.5% hyperbaric Bupivacaine is compared 
Comparator Agent  spinal anesthesia  spinal anesthesia with 0.5% Hyperbaric levobupivacaine is compared 
Comparator Agent  spinal anesthesia  spinal anesthesia with 0.75% hyperbaric Ropivacaine is compared 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  ASA I and II patients 
 
ExclusionCriteria 
Details  Allergic to local anesthetics
Unwilling for spinal anesthesia
Local site infection
Coagulopathy
Patients with cardiac, respiratory and hepatic diseases. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Duration of sensory and motor blockade  spinal time, 1st hour, 2nd hour, 3rd hour, every hourly till 24 hours 
 
Secondary Outcome  
Outcome  TimePoints 
-Onset time of sensory and motor blockade
-Maximum sensory and motor level achieved 
24 hours 
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   30/09/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Closed to Recruitment of Participants 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Patients who meet the inclusion criteria will be enrolled in the study until adequate sample size is achieved. They will be randomly divided into Groups R, L, B and they will receive 0.75% hyperbaric Ropivacaine, 0.5% hyperbaric Levobupivacaine and 0.5% hyperbaric Bupivacaine respectively. Code numbers will be written on patients proforma sheet and decoding will be done by the statistician at the end of the study. 3ml of local anesthetic will be given by an anesthetist who is not involved in the study. Data will be recorded by the investigator who is blinded to the drug injected. The onset of sensory blockade is when the patient complains of no pinprick sensation at T10. The highest level of sensory blockade achieved in each group will be noted. Time after injection of intrathecal injection of LA to the injection of first dose of rescue analgesia (Inj. Paracetamol 1gm) will be considered as duration of analgesia. The time of onset of motor blockade will be noted when patient attains bromage 3. The highest level of motor blockade achieved in each group will be noted. Duration of motor blockade is the time from spinal anesthesia till the patient is able to flex at the hip level i.e., bromage 0.  
Close